For what it is worth @Moneymaker1979 , I agree that Novartis will commit to a partnership. The data will show the value, and a therapy that works and has little or no side effects are rare it would seem. Where or what I am trying to get my head round is whether what we do is regenerative. I maybe defining it wrong, but recent results seem to show we don’t regenerate, discs or heart muscles. What we are is an anti inflammatory therapy. By reducing inflammation we enable the body to heal or maintain in the case of the heart trial. It is why early Crohns/colitis trials have been so spectacular. The key is the “sweet spot” when it comes to the best results. Look there are better posters than me. Hopefully they and you will make your case on the same thread The Investment case for Mesoblast for easy reference for learning by number people like me and new investors who will shortly come flocking.
Meanwhile let’s enjoy the wait (somehow)
regards
Yelrom
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
For what it is worth @Moneymaker1979 , I agree that Novartis...
-
- There are more pages in this discussion • 9,391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
94.5¢ | 97.5¢ | 94.0¢ | $2.076M | 2.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 162826 | 96.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 28820 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 162826 | 0.960 |
6 | 80489 | 0.955 |
6 | 62777 | 0.950 |
1 | 5500 | 0.945 |
9 | 112571 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 28820 | 3 |
0.975 | 27691 | 4 |
0.980 | 60702 | 4 |
0.985 | 70702 | 3 |
0.990 | 93055 | 5 |
Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |